期刊文献+

胃癌及癌前病变中P21,C-erbB-2和P53表达及其临床意义

The expression and its clinical meaning of C-erbB-2,P53 and P21 protein in gastric cancer and precancerous condition
暂未订购
导出
摘要 应用SP免疫组织化学染色方法检测 60例胃癌和 2 0例癌前病变中C erbB 2 ,P53和P2 1基因的过度表达 ,多基因阳性在胃癌中为 35 % ,癌前病变中为 0 % ,多基因表达明显提示胃癌预后差。C erbB 2 ,P53和P2 1的多基因表达的检测对胃癌的预后判断明显优于其中某个单基因表达的检测。 The overexpression of C erbB 2,P53 and P21 in 60 cases of gastric cancer and 20 cases of precancerous conditions were studied in SP immunohistochemistry The multiple gene positive rate in gastric cancer was 35%,and that in precancerous conditions was 0% The polygene overexpression significantly indicated poor grognosis of gastric cancers Determination of overexpression of C erbB 2,P53 and P21 simultaneously was superior to that of any single gene in evaluating the prognosis of gastric cancers
出处 《第一军医大学分校学报》 2001年第2期81-82,共2页 Journal of Branch Campus of the First Military Medical University
关键词 胃癌 癌前病变 P21 C-ERBB-2 P53 基因表达 gastric cancer precancerous condition gene expression prognosis
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部